Form 8-K - Current report:
SEC Accession No. 0001104659-24-109575
Filing Date
2024-10-17
Accepted
2024-10-17 17:07:39
Documents
15
Period of Report
2024-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426416d1_8k.htm   iXBRL 8-K 27853
2 EXHIBIT 3.1 tm2426416d1_ex3-1.htm EX-3.1 11621
3 EXHIBIT 10.1 tm2426416d1_ex10-1.htm EX-10.1 18357
  Complete submission text file 0001104659-24-109575.txt   243872

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20241011.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20241011_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20241011_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2426416d1_8k_htm.xml XML 3929
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 241378289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)